UNH director granted 41 UnitedHealth shares
Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director John H. Noseworthy received 41 shares of Common Stock as a grant tied to dividend equivalents on vested deferred stock units. These additional shares were issued at no cost and bring his directly held position to 7,410 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 41 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.
Key Figures
Key Terms
dividend equivalents financial
deferred stock units financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did UNH director John H. Noseworthy report?
Was the UNH Form 4 transaction a market purchase or sale?
What are dividend equivalents on vested deferred stock units at UNH?
Does the UNH Form 4 indicate any derivative securities activity?
AI-generated analysis. How Rhea-AI works. Not financial advice.